1. Home
  2. ITG vs BBOT Comparison

ITG vs BBOT Comparison

Compare ITG & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ITG

ITG Inc. Class A Common Stock

N/A

Current Price

$12.08

Market Cap

667.6M

Sector

Industrials

ML Signal

N/A

Logo BridgeBio Oncology Therapeutics Inc.

BBOT

BridgeBio Oncology Therapeutics Inc.

HOLD

Current Price

$8.62

Market Cap

682.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITG
BBOT
Founded
N/A
2016
Country
United States
United States
Employees
N/A
106
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
667.6M
682.5M
IPO Year
2026
N/A

Fundamental Metrics

Financial Performance
Metric
ITG
BBOT
Price
$12.08
$8.62
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$24.00
AVG Volume (30 Days)
450.5K
359.5K
Earning Date
N/A
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.37
$7.00
52 Week High
$16.00
$14.87

Technical Indicators

Market Signals
Indicator
ITG
BBOT
Relative Strength Index (RSI) 38.08 53.33
Support Level $10.37 $7.99
Resistance Level $14.40 $9.48
Average True Range (ATR) 1.52 0.57
MACD 0.03 0.01
Stochastic Oscillator 41.50 45.21

Price Performance

Historical Comparison
ITG
BBOT

About ITG ITG Inc. Class A Common Stock

ITG Inc provides services to the digital and other utility infrastructure industries throughout the United States. Its services support the planning, design, construction, operation, maintenance, and expansion of broadband and other infrastructure networks. It operates through two complementary service lines: i) Engineering & Maintenance: It provides re-occurring, mission-critical services required by network owners to operate, maintain, optimize and expand their infrastructure. ii) Infrastructure Deployment. It provides large-scale network and fiber construction services for incumbent carriers, overbuilders, and data center operators and underground civil construction services for public and private utilities. The majority of revenue is derived from the Engineering & Maintenance services.

About BBOT BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.

Share on Social Networks: